- Tytuł:
- Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)
- Autorzy:
- Źródło:
- Journal of Neuro-Oncology. 144(2):303-311
Czasopismo naukowe